---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-002248"
form_type: "8-K"
ticker: "HOTH"
cik: "0001711786"
company_name: "Hoth Therapeutics, Inc."
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:35:09.002615+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Hoth Therapeutics files patent for weight loss therapeutic and side effect mitigation

## Summary
- Filed a patent application with USPTO on January 8, 2024 for a therapeutic targeting obesity and side effects of weight loss drugs.
- Application aims to mitigate adverse effects associated with GLP-1 agonists, anticonvulsants, opioid antagonists, and NRIs.
- No details disclosed on the specific compound, mechanism, or development stage.

## SEC filing metadata
- accession: 0001213900-24-002248
- form_type: 8-K
- ticker: HOTH
- cik: 0001711786
- company_name: Hoth Therapeutics, Inc.
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711786/000121390024002248/0001213900-24-002248-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711786/000121390024002248/ea191413-8k_hoththera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-002248
- JSON: https://secwatch.observer/filing/0001213900-24-002248.json
- Plain text: https://secwatch.observer/filing/0001213900-24-002248.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.